Its GREAT listen,not biased just says its priced for growth put it in the bottom draw for three to 5 years.
- Forums
- ASX - By Stock
- DSE
- Ann: Investor Presentation Q4 2023 Update
Ann: Investor Presentation Q4 2023 Update, page-8
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DSE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.40 |
Change
-0.010(0.29%) |
Mkt cap ! $238.8M |
Open | High | Low | Value | Volume |
$3.41 | $3.41 | $3.35 | $67.94K | 19.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1350 | $3.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.42 | 144 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1350 | 3.400 |
1 | 305 | 3.280 |
1 | 1353 | 3.270 |
1 | 308 | 3.250 |
3 | 2622 | 3.200 |
Price($) | Vol. | No. |
---|---|---|
3.420 | 144 | 1 |
3.440 | 10000 | 1 |
3.450 | 116036 | 1 |
3.460 | 46974 | 1 |
3.500 | 50127 | 3 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
DSE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online